{"id":"https://openalex.org/W4396800524","doi":"https://doi.org/10.1107/s2053273323092690","title":"Rapid hits, hotspots and hit-to-lead by crystallographic library screening: case studies in targeting proteins for novel drug discovery","display_name":"Rapid hits, hotspots and hit-to-lead by crystallographic library screening: case studies in targeting proteins for novel drug discovery","publication_year":2023,"publication_date":"2023-08-22","ids":{"openalex":"https://openalex.org/W4396800524","doi":"https://doi.org/10.1107/s2053273323092690"},"language":"en","primary_location":{"id":"doi:10.1107/s2053273323092690","doi":"https://doi.org/10.1107/s2053273323092690","is_oa":true,"landing_page_url":"http://doi.org/10.1107/s2053273323092690","pdf_url":"http://dx.doi.org/10.1107/s2053273323092690","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://dx.doi.org/10.1107/s2053273323092690","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103261223","display_name":"Debanu Das","orcid":"https://orcid.org/0000-0001-6019-6760","observed_orcids":["https://orcid.org/0000-0001-6019-6760"]},"institutions":[{"id":"https://openalex.org/I4387155997","display_name":"Accelero Biostructures","ror":"https://ror.org/04b8eax48","country_code":"US","type":"company","lineage":["https://openalex.org/I4387155997"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debanu Das","raw_affiliation_strings":["Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","Accelero Biostructures, California, USA;","XPose Therapeutics, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"Accelero Biostructures, California, USA;","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"XPose Therapeutics, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078538865","display_name":"Ashley M. Deacon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155997","display_name":"Accelero Biostructures","ror":"https://ror.org/04b8eax48","country_code":"US","type":"company","lineage":["https://openalex.org/I4387155997"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Deacon","raw_affiliation_strings":["Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","Accelero Biostructures, California, USA;","XPose Therapeutics, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"Accelero Biostructures, California, USA;","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"XPose Therapeutics, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041051375","display_name":"Matthew A. J. Duncton","orcid":"https://orcid.org/0000-0002-6007-7515","observed_orcids":["https://orcid.org/0000-0002-6007-7515"]},"institutions":[{"id":"https://openalex.org/I4387155997","display_name":"Accelero Biostructures","ror":"https://ror.org/04b8eax48","country_code":"US","type":"company","lineage":["https://openalex.org/I4387155997"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Duncton","raw_affiliation_strings":["Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","Accelero Biostructures, California, USA;","XPose Therapeutics, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Accelero Biostructures , California , USA; XPose Therapeutics , California , USA","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"Accelero Biostructures, California, USA;","institution_ids":["https://openalex.org/I4387155997"]},{"raw_affiliation_string":"XPose Therapeutics, California, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4387155997"],"apc_list":{"value":4220,"currency":"USD","value_usd":4220},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12080913,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"a2","first_page":"C346","last_page":"C346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.03750000149011612,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hot-spots","display_name":"hot spots","score":0.824999988079071},{"id":"https://openalex.org/keywords/hit-to-lead","display_name":"hit-to-lead optimization","score":0.8960000276565552},{"id":"https://openalex.org/keywords/target-proteins","display_name":"protein targets","score":0.5419999957084656},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.7099999785423279},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.6060000061988831},{"id":"https://openalex.org/keywords/protein-ligand-interactions","display_name":"protein-ligand interactions","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7482374906539917},{"id":"https://openalex.org/C2777093003","wikidata":"https://www.wikidata.org/wiki/Q6508345","display_name":"Lead (geology)","level":2,"score":0.5579831600189209},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.544707715511322},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4628452658653259},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3729841709136963},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35461682081222534},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.324665367603302},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2379138171672821},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19907310605049133},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15655595064163208},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1107/s2053273323092690","doi":"https://doi.org/10.1107/s2053273323092690","is_oa":true,"landing_page_url":"http://doi.org/10.1107/s2053273323092690","pdf_url":"http://dx.doi.org/10.1107/s2053273323092690","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1107/s2053273323092690","doi":"https://doi.org/10.1107/s2053273323092690","is_oa":true,"landing_page_url":"http://doi.org/10.1107/s2053273323092690","pdf_url":"http://dx.doi.org/10.1107/s2053273323092690","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396800524.pdf","grobid_xml":"https://content.openalex.org/works/W4396800524.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W3093760363"],"related_works":["https://openalex.org/W2998366151","https://openalex.org/W2941656631","https://openalex.org/W2332673065","https://openalex.org/W4230178070","https://openalex.org/W2504789772","https://openalex.org/W2994898134","https://openalex.org/W4311737807","https://openalex.org/W4327800606","https://openalex.org/W2114963860","https://openalex.org/W111555371"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-05-11T00:00:00"}